AARTI PHARMALABS to meet investors on May 28

0 min read     Updated on 20 May 2026, 05:33 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

AARTI PHARMALABS LIMITED announced it will hold a meeting with investors and analysts on May 28, 2026, at the 360 ONE Capital Conference. The meeting will be held in physical mode to discuss ordinary business.

powered bylight_fuzz_icon
40824188

*this image is generated using AI for illustrative purposes only.

AARTI PHARMALABS LIMITED has scheduled a meeting with investors and analysts to discuss the ordinary course of business. The interaction is set to take place on Thursday, May 28, 2026, as part of the 360 ONE Capital Conference - Trinity 2026.

The company will engage in both one-on-one and group meetings during the event. The session will be conducted via physical mode. AARTI PHARMALABS noted that the schedule may be subject to changes depending on the analysts, institutional investors, or the company.

Event Details

The following table outlines the specifics of the upcoming conference:

Day and Date Name of the Event Mode
Thursday, May 28, 2026 360 ONE Capital Conference - Trinity 2026 Physical Mode

The company clarified that no unpublished price sensitive information pertaining to the company will be shared during the said meeting. The intimation was made to the stock exchanges in compliance with Regulation 30 of the SEBI (LODR) Regulations 2015.

Historical Stock Returns for Aarti Pharma Labs

1 Day5 Days1 Month6 Months1 Year5 Years
-0.73%-1.68%+0.43%-1.07%-18.06%+143.10%

What strategic growth initiatives or expansion plans might Aarti PharmaLabs highlight to institutional investors at the 360 ONE Capital Conference?

How could increased institutional investor interest following the conference impact Aarti PharmaLabs' stock liquidity and valuation multiples?

What key financial metrics or pipeline developments are analysts likely to scrutinize when evaluating Aarti PharmaLabs' near-term outlook?

Aarti Pharmalabs schedules Q4 FY26 earnings call

1 min read     Updated on 20 May 2026, 11:29 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Aarti Pharmalabs Limited will hold an earnings conference call on May 26, 2026, at 4:00 PM IST to discuss its Q4 FY26 financial results. The call will be attended by Chairman Mr. Rashesh Gogri, Vice Chairperson and Managing Director Mrs. Hetal Gogri Gala, and CFO Mr. Piyush Lakhani. Participants must pre-register via the provided Zoom link to attend.

powered bylight_fuzz_icon
40802369

*this image is generated using AI for illustrative purposes only.

Aarti Pharmalabs Limited has scheduled an earnings conference call to discuss its financial results for the fourth quarter of the fiscal year 2026. The meeting is set to take place on Tuesday, May 26, 2026, at 4:00 PM IST. The announcement was made in accordance with Regulation 30 of the SEBI (LODR) Regulations, 2015.

The conference call is open to investors and analysts interested in the company's performance for the quarter ending March 31, 2026. Aarti Pharmalabs Limited has provided a registration link for participants to join the session virtually.

Management Participants

The discussion will feature key members of the company's leadership team. The following executives are scheduled to participate in the call:

  • Mr. Rashesh Gogri - Chairman
  • Mrs. Hetal Gogri Gala - Vice Chairperson and Managing Director
  • Mr. Piyush Lakhani - Chief Financial Officer

Conference Call Details

Investors and analysts are requested to pre-register for the call using the provided URL to ensure access. The logistical details for the event are outlined below:

Detail Information
Date Tuesday, May 26, 2026
Time 4:00 PM IST
Platform Zoom Webinar
Registration Link Zoom Registration

For further information regarding the conference call, participants may contact Mr. Sidharth Jain via email at sidharth.jain@ysil.in or by phone at +91 96191 63164.

Historical Stock Returns for Aarti Pharma Labs

1 Day5 Days1 Month6 Months1 Year5 Years
-0.73%-1.68%+0.43%-1.07%-18.06%+143.10%

How is Aarti Pharmalabs expected to perform in Q4 FY2026 compared to its peers in the pharmaceutical contract manufacturing space amid evolving global supply chain dynamics?

Will management provide guidance on potential capacity expansion or new API segments as part of their FY2027 strategic outlook during the earnings call?

How might recent regulatory changes in key export markets like the US and Europe impact Aarti Pharmalabs' revenue mix and margins going forward?

More News on Aarti Pharma Labs

1 Year Returns:-18.06%